Report Highlights
- The U.S. market for medical automation technologies was worth an estimated $12 billion in 2008. This market is projected to grow to $13.1 billion in 2009 and to $23.2 billion by 2014, a compound annual growth rate (CAGR) of 12.2% over the next 5 years.
- Therapeutic applications account for the largest share of the medical automation market, with 73% in 2008, declining slightly to 72% by 2014.
- Diagnostic and monitoring applications represent about a quarter of the market, with $3 billion in sales in 2008. That is expected to rise to $3.3 billion in 2009 and to nearly $5.9 billion in 2014, for a CAGR of 12.4%.
INTRODUCTION
- Identifying the medical automation technologies with the greatest commercial potential over the next 5 years (2009 to 2014)
- Estimating the market for these technologies in 2007 to 2008
- Analyzing the technical, economic and other demand drivers for these products, and other prerequisites of success in these markets
- Projecting the potential U.S. markets for these technologies through 2014.
- Automated health assessment and monitoring technologies
- Automated medical imaging and image analysis
- Automated prescription fulfillment devices
- Automated therapeutic (nonsurgical) devices
- Robotic and computer-assisted surgical equipment
- Automated laboratory testing and analysis
- Automated healthcare logistics, resource, and patient tracking
- Automated medical training
The study format includes the following major elements:
- Executive summary
- Definitions
- Medical automation technologies and applications
- Enabling technologies
- End-user segments
- Market environment (legal and regulatory, standards, economic conditions, consumer attitudes)
- Current (2007 and 2008) and projected market for medical automation technologies and products through 2014
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Renal Disease Treatments: Products and Therapies
The global market for renal disease treatments was valued at $60.8 billion in 2025, and it is estimated to increase from $65.7 billion in 2026 to reach $99.8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 through 2031.
State of the Life Sciences Industry - 2026 Third Quarter Review
Review Q3 2026 life sciences trends, including market shifts, emerging technologies, industry activity and the sector outlook.
Latest Development, Product Innovations, and Treatments for Diabetes
The global market for latest developments, product innovations, and treatments for diabetes was valued at $144.5 billion in 2025 and is estimated to increase from $162.2 billion in 2026 to reach $295 billion by the end of 2031, at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2031.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.
Liquid Biopsy with Emphasis on Cancer: Global Markets
The global market for liquid biopsy with emphasis on cancer is expected to grow from $4.1 billion in 2026 and is projected to reach $8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 14.1% during the forecast period of 2026 to 2031.
Top Trending Reports
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
Agricultural Biotechnology: Emerging Technologies and Global Markets
The global agricultural biotechnology market was valued at an estimated $84.7 billion in 2025 and is estimated to increase from $91.5 billion in 2026 to reach $137 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2031.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More